NCT01970787View on ClinicalTrials.gov

A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions
Interventions
DEVICE

Radiofrequency Ablation (RFA) using the HALO Ablation System

Trial Locations (1)

10011

Laser Surgery Center, New York

Sponsors

Lead Sponsor

Medtronic - MITG
All Listed Sponsors
lead

Medtronic - MITG

INDUSTRY

NCT01970787 - A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System | Biotech Hunter | Biotech Hunter